Therapeutic benefit of adjuvant active specific immunotherapy (A.S.I.) with autologous tumor-vaccines in patients with colon cancer. Results of a randomised fase III study
A.M.E. Claessen, A. Stam, E. Bloemena, H. Gall, J.B. Vermorken, R.J. Scheper, H.M. Pinedo, C.J.L.M. MeijerVolume:
56
Year:
1997
Language:
english
DOI:
10.1016/s0165-2478(97)85854-3
File:
PDF, 185 KB
english, 1997